Jane L. Messina

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

David H. Munn, Madhav Sharma, De‐Yan Hou et al. · Journal of Clinical Investigation · 2004 · 839 citations · Full text

Immunology, Immunoediting, Immunologic Mechanism +18

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

Adil Daud, Ronald C. DeConti, Stephanie Andrews et al. · Journal of Clinical Oncology · 2008 · 680 citations · Full text

PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression

Kim H.T. Paraiso, Yun Xiang, Vito W. Rebecca et al. · Cancer Research · 2011 · 544 citations · Full text

Cancer Research, Cell Regulation, Medicine +15

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

Jane L. Messina, David Fenstermacher, Steven A. Eschrich et al. · Scientific Reports · 2012 · 411 citations · Full text

High response rate to PD-1 blockade in desmoplastic melanomas

Zeynep Eroglu, Jesse M. Zaretsky, Siwen Hu‐Lieskovan et al. · Nature · 2018 · 326 citations · Full text

Melanoma, High Response Rate, Immune Checkpoint Inhibitor +4